NSW COVID: Sydney patients developed 'resistance' to common

Sotrovimab, a treatment administered via intravenous drip to patients considered to be at risk of severe disease from the virus, has been widely used at hospitals.

Related Keywords

Australia , Sydney , New South Wales , Mary Ward , Doherty Institute , Twitter , Most Viewed In National , Professor Steven Tong , Morning Edition , Sydney Morning Herald Connect , ,